Atlas Trials

Effects of Bilastine on F1 Simulator Driving Performance in Patients Affected by Allergic Rhinitis and/or Urticaria

Clinical trial NCT02576041 · COMPLETED

Trial details

NCT number
NCT02576041
Sponsor
Menarini International Operations Luxembourg SA
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Allergic RhinitisUrticaria
Start date
2015-10-01
Primary completion
2015-12-01
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.